Dingemans AM - Search Results

1

MicroRNA expression and clinical outcome of small cell lung cancer.

Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G. Lee JH, et al. Among authors: dingemans am. PLoS One. 2011;6(6):e21300. doi: 10.1371/journal.pone.0021300. Epub 2011 Jun 22. PLoS One. 2011. PMID: 21731696 Free PMC article.

2

MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.

Giaccone G, van Ark-Otte J, Rubio GJ, Gazdar AF, Broxterman HJ, Dingemans AM, Flens MJ, Scheper RJ, Pinedo HM. Giaccone G, et al. Among authors: dingemans am. Int J Cancer. 1996 Jun 11;66(6):760-7. doi: 10.1002/(SICI)1097-0215(19960611)66:6<760::AID-IJC9>3.0.CO;2-Y. Int J Cancer. 1996. PMID: 8647646 Free article.

3

[Role of chemotherapy in non-small cell lung carcinoma].

Giaccone G, Dingemans AM. Giaccone G, et al. Among authors: dingemans am. Ned Tijdschr Geneeskd. 1996 May 25;140(21):1111-4. Ned Tijdschr Geneeskd. 1996. PMID: 8692336 Review. Dutch. No abstract available.

4

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

Apolinario RM, van der Valk P, de Jong JS, Deville W, van Ark-Otte J, Dingemans AM, van Mourik JC, Postmus PE, Pinedo HM, Giaccone G. Apolinario RM, et al. Among authors: dingemans am. J Clin Oncol. 1997 Jun;15(6):2456-66. doi: 10.1200/JCO.1997.15.6.2456. J Clin Oncol. 1997. PMID: 9196162

5

Determinants of CPT-11 and SN-38 activities in human lung cancer cells.

van Ark-Otte J, Kedde MA, van der Vijgh WJ, Dingemans AM, Jansen WJ, Pinedo HM, Boven E, Giaccone G. van Ark-Otte J, et al. Among authors: dingemans am. Br J Cancer. 1998 Jun;77(12):2171-6. doi: 10.1038/bjc.1998.362. Br J Cancer. 1998. PMID: 9649129 Free PMC article.

6

Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.

Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G. Dingemans AM, et al. Clin Cancer Res. 1999 Aug;5(8):2048-58. Clin Cancer Res. 1999. PMID: 10473085 Clinical Trial.

7

Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues.

Dingemans AM, van Ark-Otte J, van der Valk P, Apolinario RM, Scheper RJ, Postmus PE, Giaccone G. Dingemans AM, et al. Ann Oncol. 1996 Aug;7(6):625-30. doi: 10.1093/oxfordjournals.annonc.a010681. Ann Oncol. 1996. PMID: 8879378 Free article.

8

Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samples.

Dingemans AM, Van Ark-Otte J, Smit EF, Postmus PE, Giaccone G. Dingemans AM, et al. Anticancer Res. 2000 Sep-Oct;20(5B):3549-54. Anticancer Res. 2000. PMID: 11131661

9

Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.

Dingemans AM, Brakenhoff RH, Postmus PE, Giaccone G. Dingemans AM, et al. Lab Invest. 1997 Sep;77(3):213-20. Lab Invest. 1997. PMID: 9314945

10

Clinical resistance to topoisomerase-targeted drugs.

Dingemans AM, Pinedo HM, Giaccone G. Dingemans AM, et al. Biochim Biophys Acta. 1998 Oct 1;1400(1-3):275-88. doi: 10.1016/s0167-4781(98)00141-9. Biochim Biophys Acta. 1998. PMID: 9748627 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page